Department of Endocrinology, diabetes and metabolic diseases, Clinic for Internal Medicine, Clinical Center Kragujevac, Kragujevac, 34000, Zmaj Jovina st. 30, Serbia
Department of Endocrinology, diabetes and metabolic diseases, Clinic for Internal Medicine, Clinical Center Kragujevac, Kragujevac, 34000, Zmaj Jovina st. 30, Serbia
Department of Clinical Pharmacology, Clinical Center Kragujevac, Kragujevac, 34000, Zmaj Jovina st. 30, Serbia
References
[1] Steffensen C., Bak A.M., Rubeck K.Z., Jorgensen J.O., Epidemiology of Cushing’s syndrome, Neuroendocrinology, 2010, 92Suppl 1:1–5 http://dx.doi.org/10.1159/000314297[WoS][Crossref]
[2] Alves M., Neves C., Medina J.L., Laboratorial diagnosis of Cushing’s syndrome, Acta Med Port., 2010, 23(1),63–67
[3] Aron D.C., Cushing’s syndrome: why is diagnosis so difficult? Rev. Endocr. Metab. Disord. 2010, 11(2):105–116 http://dx.doi.org/10.1007/s11154-010-9127-3[Crossref][WoS]
[4] Vilar. L, Freitas Mda. C., Faria M., Montenegro R., Casulari L.A., Naves L., Bruno O.D., Pitfalls in the diagnosis of Cushing’s syndrome, Arq. Bras. Endocrino.l Metabol., 2007, 51(8),1207–1216 [Crossref]
[5] Santos S., Santos E., Gaztambide S., Salvador J., Diagnosis and differential diagnosis of Cushing’s syndrome, Endocrinol. Nutr., 2009, 56(2),71–84 http://dx.doi.org/10.1016/S1575-0922(09)70555-8[Crossref]
[6] Bolland M.J., Holdaway I.M., Berkeley J.E., Lim S., Dransfield W.J., Conaglen J.V., et al., Mortality and Morbidity in Cushing’s syndrome in New Zeland, Clin. Endocrinol. (Oxf.), 2011, May 24.doi 10.1111/j.1365-2265.,2011,014124 [Crossref]
[8] Szappanos A., Toke J., Lippai D., Patocs A., Szucs N., Futo L., et al., Bone turnover in patients with endogenous Cushing’s syndrome before and after succesful treatment., Osteoporos. Int., 2010, 21(4):637–645 http://dx.doi.org/10.1007/s00198-009-0978-y[Crossref]
[9] Bednarek-Tupikowska G., Kubicka E., Hypercortisolism in pregnancy, Pol. Merkur Lekarski. 2006, 20(116),232–235
[10] Peris P., Guanabens N., Martinez de Osaba M.J., Monegal A., Alvarez L., Pons F., et al., Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women, Semin. Arthritis. Rheum. 2002, 32(1),64–70 http://dx.doi.org/10.1053/sarh.2002.33725[Crossref]
[11] Randazzo M.E., Grossrubatscher E., Dalino Ciaramella P., Vanzulli A., Lili P., Spontaneous recovery of bone mass after cure of endogenous hypercortisolism, Pituitary, 2011 Apr 8. DOI: 10.1007/ s11102-011-0306-3 [WoS][Crossref]
[12] Takeshita M., Mizuno Y., Effect of glucose and bone metabolism in endocrinal disorder, Clin. Calcium., 2009, 19(9),1282–1290
[13] Smets P., Meyer E., Maddens B., Daminet S., Cushing’s syndrome, glucocorticoids and the kidney, Gen. Comp. Endocrinol., 2010, 169(1),1–10. http://dx.doi.org/10.1016/j.ygcen.2010.07.004[WoS][Crossref]
[14] Bruno O.D., Juarez-Allen L., Rossi M.A., Longobardi V., In what clinical settings should Cushing’s syndrome be suspected?, Medicina (B. Aires). 2009, 69(6),674–680
[15] Kalantaridou S.N., Makrigiannakis A., Zoumakis E., Chrousos G.P., Stress and female reproductive system, J. Reprod. Immunol., 2004, 62(1–2),61–68 http://dx.doi.org/10.1016/j.jri.2003.09.004[Crossref]
[17] Wolkowitz O.M., Burke H., Epel E.S., Reus V.I., Glucocorticoids. Mood, memory, and mechanisms, Ann. N Y Acad. Sci., 2009, 1179,19–40 http://dx.doi.org/10.1111/j.1749-6632.2009.04980.x[Crossref]
[18] Manetti L., Bogazzi F., Giovannetti C., Raffaelli V., Genovesi M., Pellegrini G., et al., Changes in coagulation indexes and occurence of venous thromboembolism in patients with Cushing’s syndrome: result from a prospective study before and after surgery, Eur. J. Endocrinol., 2010, 163(5),783–1891 http://dx.doi.org/10.1530/EJE-10-0583[WoS][Crossref]
[19] Van Zaane B., Nur E., Sqizzato A., Dekkers O.M., Twickler M.T., Fliers E., et al., Hypercoagulable state in Cushing’s syndrome: a systematic review, J. Clin. Endocrinol. Metab., 2009, 94(8),2743–2750 http://dx.doi.org/10.1210/jc.2009-0290[Crossref]
[20] Erem C., Nuhoglu I., Yilmaz M., Kocak M., Demirel A., Ucuncu O., et al., Blood coagulation and fibrinolysis in patient with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels, J. Endocrinol. Invest., 2009,32(2),169–1674 [WoS][Crossref]
[21] Kita M., Sakalidou M., Saratzis A., Ioannis S., Avramidis A., Cushing’s syndrome in pregnancy: report of a case and review of the literature, Hormones (Athens), 2007, 6(3),242–246
[22] Bertherat J., Bilaud L., Guilhaume B., Cushing’s syndrome and adrenal insuffiency in pregnancy, Ann. Endocrinol. (Paris), 2002, Oct,63(5),452–456
[23] Delibasi T., Ustun I., Aydin Y., Berker D., Erol H.K., Gul K., et al., Early severe pre-eclamptic findings in a patient with Cushing’s syndrome. Gynecol. Endocrinol., 2006, 22(12),710–712 http://dx.doi.org/10.1080/09513590601069447[Crossref]
[24] Lindsay J.R., Nieman L.K., The hypotalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment, Endoc. Rev., 2005, 26(6),775–799 http://dx.doi.org/10.1210/er.2004-0025[Crossref]
[25] Vilar L., Freitas Mda C., Lima L.H., Lyra R., Kater C.E., Cushing’s syndrome in pregnancy: an overview, Arq. Bras. Endocrinol. Metabol., 2007, 51(8),1293–1302
[26] Bednarek-Tupikowska G., Kubicka E., Hypercortisolism in pregnancy, Pol. Merkur Lekarski, 2006, 20(116),232–235
[28] Terhune K.P., Jagasia S., Blevins L.S.Jr., Phay J.E., Diagnostic and therapeutic dilemmas of hypercortisolemia during pregnancy: a case report. Am. surg., 2009, 75(3),232–234
[29] Lo C.Y., Lo C.M., Lam K.Y., Cushing’s syndrome secondary to adrenal adenoma during pregnancy, Surg Endosc., 2002,16(1),219–220 [Crossref]
[30] Kim Hg, Lee K.H., Je G.H., Han M.S., A case of Cushing’s syndrome in pregnancy secondary to an adrenal cortical adenoma, J. Korean Med. Sci., 2003, 18(3),444–446 [Crossref]
[31] Choi WJ, Jung TS, Paik WY. Cushing’s syndrome in pregnancy with a severe maternal complication: a case report. J Obstet Gynaecol Res. 2011,Feb;37(2):163–167 http://dx.doi.org/10.1111/j.1447-0756.2010.01339.x[Crossref]
[32] Sammour RN, Saiegh L, Matter I, Gonen R, Shechner C, Cohen M, Ohel G Dickstein G. Adrenalectomy for adrenocortical adenoma causing Cushing’s syndrome in pregnancy: a case report and review of literature. Eur J Obstet Gynecol Reprod Biol. 2012 Jun 13. [Epub ahead of print] PubMed PMID: 22698457
[33] Holgado-Galicia MV, Magno JD, Acelajado-Valdenor C, Isip-Tan IT, Lim-Abrahan MA. Cushing’s syndrome in pregnancy. BMJ Case Rep. 2011 Apr 26;2011. pii: bcr0120113720. doi: 10.1136/bcr.01.2011.3720. PubMed PMID: 22696666
[34] Homer L, Viatge M, Gayet FX, Laurent Y, Kerlan V. [Cushing syndrome and pregnancy: a propos of a malignant adrenocortical carcinoma]. Gynecol Obstet Fertil. 2012 Mar;40(3):e1–4 http://dx.doi.org/10.1016/j.gyobfe.2011.07.053[Crossref]
[35] Kotteas E, Ioachim E, Pavlidis N. A pregnant patient with adrenocortical carcinoma: case report. Onkologie. 2012;35(9):517–951 http://dx.doi.org/10.1159/000341830[Crossref][WoS]
[36] Lubin V, Gautier JF, Antoine JM, Beressi JP, Vexiau P. Cushing’s syndrome during pregnancy. Presse Med. 2002; 31(36):1706–1713